173 related articles for article (PubMed ID: 27102768)
1. Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy.
Tinklenberg J; Meng H; Yang L; Liu F; Hoffmann RG; Dasgupta M; Allen KP; Beggs AH; Hardeman EC; Pearsall RS; Fitts RH; Lawlor MW
Am J Pathol; 2016 Jun; 186(6):1568-81. PubMed ID: 27102768
[TBL] [Abstract][Full Text] [Related]
2. Myostatin Inhibition Using ActRIIB-mFc Does Not Produce Weight Gain or Strength in the Nebulin Conditional KO Mouse.
Tinklenberg JA; Siebers EM; Beatka MJ; Fickau BA; Ayres S; Meng H; Yang L; Simpson P; Granzier HL; Lawlor MW
J Neuropathol Exp Neurol; 2019 Feb; 78(2):130-139. PubMed ID: 30597051
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathy.
Nguyen MA; Joya JE; Kee AJ; Domazetovska A; Yang N; Hook JW; Lemckert FA; Kettle E; Valova VA; Robinson PJ; North KN; Gunning PW; Mitchell CA; Hardeman EC
Brain; 2011 Dec; 134(Pt 12):3516-29. PubMed ID: 22067542
[TBL] [Abstract][Full Text] [Related]
4. Combined MRI and ³¹P-MRS investigations of the ACTA1(H40Y) mouse model of nemaline myopathy show impaired muscle function and altered energy metabolism.
Gineste C; Le Fur Y; Vilmen C; Le Troter A; Pecchi E; Cozzone PJ; Hardeman EC; Bendahan D; Gondin J
PLoS One; 2013; 8(4):e61517. PubMed ID: 23613869
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice.
Lawlor MW; Read BP; Edelstein R; Yang N; Pierson CR; Stein MJ; Wermer-Colan A; Buj-Bello A; Lachey JL; Seehra JS; Beggs AH
Am J Pathol; 2011 Feb; 178(2):784-93. PubMed ID: 21281811
[TBL] [Abstract][Full Text] [Related]
6. ACTA1 H40Y mutant iPSC-derived skeletal myocytes display mitochondrial defects in an in vitro model of nemaline myopathy.
Gartz M; Haberman M; Sutton J; Slick RA; Luttrell SM; Mack DL; Lawlor MW
Exp Cell Res; 2023 Mar; 424(2):113507. PubMed ID: 36796746
[TBL] [Abstract][Full Text] [Related]
7. Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice.
Tinklenberg JA; Siebers EM; Beatka MJ; Meng H; Yang L; Zhang Z; Ross JA; Ochala J; Morris C; Owens JM; Laing NG; Nowak KJ; Lawlor MW
Hum Mol Genet; 2018 Feb; 27(4):638-648. PubMed ID: 29293963
[TBL] [Abstract][Full Text] [Related]
8. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis.
Morrison BM; Lachey JL; Warsing LC; Ting BL; Pullen AE; Underwood KW; Kumar R; Sako D; Grinberg A; Wong V; Colantuoni E; Seehra JS; Wagner KR
Exp Neurol; 2009 Jun; 217(2):258-68. PubMed ID: 19285073
[TBL] [Abstract][Full Text] [Related]
9. Morphological and functional alterations of neuromuscular synapses in a mouse model of ACTA1 congenital myopathy.
Liu Y; Lin W
Hum Mol Genet; 2024 Jan; 33(3):233-244. PubMed ID: 37883471
[TBL] [Abstract][Full Text] [Related]
10. Actin nemaline myopathy mouse reproduces disease, suggests other actin disease phenotypes and provides cautionary note on muscle transgene expression.
Ravenscroft G; Jackaman C; Sewry CA; McNamara E; Squire SE; Potter AC; Papadimitriou J; Griffiths LM; Bakker AJ; Davies KE; Laing NG; Nowak KJ
PLoS One; 2011; 6(12):e28699. PubMed ID: 22174871
[TBL] [Abstract][Full Text] [Related]
11. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
[TBL] [Abstract][Full Text] [Related]
12. Severe ACTA1-related nemaline myopathy: intranuclear rods, cytoplasmic bodies, and enlarged perinuclear space as characteristic pathological features on muscle biopsies.
Labasse C; Brochier G; Taratuto AL; Cadot B; Rendu J; Monges S; Biancalana V; Quijano-Roy S; Bui MT; Chanut A; Madelaine A; Lacène E; Beuvin M; Amthor H; Servais L; de Feraudy Y; Erro M; Saccoliti M; Neto OA; Fauré J; Lannes B; Laugel V; Coppens S; Lubieniecki F; Bello AB; Laing N; Evangelista T; Laporte J; Böhm J; Romero NB
Acta Neuropathol Commun; 2022 Jul; 10(1):101. PubMed ID: 35810298
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Histologic Findings in ACTA1-Related Nemaline Myopathy: Case Series and Review of the Literature.
Moreno CAM; Abath Neto O; Donkervoort S; Hu Y; Reed UC; Oliveira ASB; Bönnemann C; Zanoteli E
Pediatr Neurol; 2017 Oct; 75():11-16. PubMed ID: 28780987
[TBL] [Abstract][Full Text] [Related]
14. Different Mouse Models of Nemaline Myopathy Harboring Acta1 Mutations Display Differing Abnormalities Related to Mitochondrial Biology.
Tinklenberg JA; Slick RA; Sutton J; Zhang L; Meng H; Beatka MJ; Vanden Avond M; Prom MJ; Ott E; Montanaro F; Heisner J; Toro R; Hardeman EC; Geurts AM; Stowe DF; Hill RB; Lawlor MW
Am J Pathol; 2023 Oct; 193(10):1548-1567. PubMed ID: 37419385
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant distal myopathy with nemaline rods due to p.Glu197Asp mutation in ACTA1.
Hernandez-Lain A; Cantero D; Camacho-Salas A; Toldos O; Esteban I; Pascual I; Dominguez-Gonzalez C
Neuromuscul Disord; 2019 Mar; 29(3):247-250. PubMed ID: 30732915
[TBL] [Abstract][Full Text] [Related]
16. Akt deficiency attenuates muscle size and function but not the response to ActRIIB inhibition.
Goncalves MD; Pistilli EE; Balduzzi A; Birnbaum MJ; Lachey J; Khurana TS; Ahima RS
PLoS One; 2010 Sep; 5(9):e12707. PubMed ID: 20856813
[TBL] [Abstract][Full Text] [Related]
17. A soluble activin receptor type IIb prevents the effects of androgen deprivation on body composition and bone health.
Koncarevic A; Cornwall-Brady M; Pullen A; Davies M; Sako D; Liu J; Kumar R; Tomkinson K; Baker T; Umiker B; Monnell T; Grinberg AV; Liharska K; Underwood KW; Ucran JA; Howard E; Barberio J; Spaits M; Pearsall S; Seehra J; Lachey J
Endocrinology; 2010 Sep; 151(9):4289-300. PubMed ID: 20573726
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of nemaline myopathy cases with skeletal muscle alpha-actin gene mutations.
Agrawal PB; Strickland CD; Midgett C; Morales A; Newburger DE; Poulos MA; Tomczak KK; Ryan MM; Iannaccone ST; Crawford TO; Laing NG; Beggs AH
Ann Neurol; 2004 Jul; 56(1):86-96. PubMed ID: 15236405
[TBL] [Abstract][Full Text] [Related]
19. Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.
Puolakkainen T; Ma H; Kainulainen H; Pasternack A; Rantalainen T; Ritvos O; Heikinheimo K; Hulmi JJ; Kiviranta R
BMC Musculoskelet Disord; 2017 Jan; 18(1):20. PubMed ID: 28103859
[TBL] [Abstract][Full Text] [Related]
20. Multimodal MRI and (31)P-MRS investigations of the ACTA1(Asp286Gly) mouse model of nemaline myopathy provide evidence of impaired in vivo muscle function, altered muscle structure and disturbed energy metabolism.
Gineste C; Duhamel G; Le Fur Y; Vilmen C; Cozzone PJ; Nowak KJ; Bendahan D; Gondin J
PLoS One; 2013; 8(8):e72294. PubMed ID: 23977274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
